Cytokine interactions that determine the outcome of mycobacterial infection of macrophages

Cytokine

Volumn 51, Issue 1, 2010, Pages 42-46

  Reljic, Rajko ^a   Stylianou, Elena ^a   Balu, Sucharitha ^b   Ma, Julian K ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cytokines; Infection; Macrophage; Nitric oxide; Tuberculosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; IN VITRO STUDY; MACROPHAGE; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; TH2 CELL; TUBERCULOSIS;

ANIMALS; CELL LINE; CYTOKINES; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-4; MACROPHAGES, PERITONEAL; MICE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM INFECTIONS; NITRIC OXIDE;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM BOVIS;

EID: 77953360089     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.04.005     Document Type: Article

References (28)

1. Armstrong J.A., Hart P.D. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle-bacilli - reversal of usual nonfusion pattern and observations on bacterial survival. J Exp Med 1975, 142:1-16.
2. Clemens D.L., Horwitz M.A. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med 1995, 181:257-270.
3. Deretic V., Fratti R.A. Mycobacterium tuberculosis phagosome. Mol Microbiol 1999, 31:1603-1609.
4. Chan J., Xing Y., Magliozzo R.S., Bloom B.R. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992, 175:1111-1122.
5. Chan J., Tanaka K., Carroll D., Flynn J., Bloom B.R. Effects of nitric-oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 1995, 63:736-740.
6. Nathan C., Shiloh M.U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 2000, 97:8841-8848.
7. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997, 15:323-350.
8. Champsi J.H., Bermudez L.E., Young L.S. The role of cytokines in mycobacterial infection. Biotherapy 1994, 7:187-193.
9. Flesch I., Kaufmann S.H.E. Mycobacterial growth-inhibition by interferon-gamma-activated bone-marrow macrophages. Immunobiology 1987, 175:277-278.
10. Flynn J.L., Goldstein M.M., Chan J., Triebold K.J., Pfeffer K., Lowenstein C.J., et al. Tumor-necrosis-factor-alpha is required in the protective immune-response against Mycobacterium tuberculosis in mice. Immunity 1995, 2:561-572.
11. Lake F.R., Noble P.W., Henson P.M., Riches D.W.H. Functional switching of macrophage responses to tumor-necrosis-factor-alpha (TNF-alpha) by interferons - implications for the pleiotropic activities of TNF-alpha. J Clin Invest 1994, 93:1661-1669.
12. Rook G.A.W. Th2 cytokines in susceptibility to tuberculosis. Curr Mol Med 2007, 7:327-337.
13. Schreiber T., Ehlers S., Heitmann L., Rausch A., Mages J., Murray P.J., et al. Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J Immunol 2009, 183:1301-1312.
14. Kampmann B., Gaora P.O., Snewin V.A., Gares M.P., Young D.B., Levin M. Evaluation of human antimycobacterial immunity using recombinant reporter mycobacteria. J Infect Dis 2000, 182:895-901.
15. Snewin V.A., Gares M.P., Gaora P.O., Hasan Z., Brown I.N., Young D.B. Assessment of immunity to mycobacterial infection with luciferase reporter constructs. Infect Immun 1999, 67:4586-4593.
16. Varin A., Gordon S. Alternative activation of macrophages: immune function and cellular biology. Immunobiology 2009, 214:630-641.
17. Weiss G., Bogdan C., Hentze M.W. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J Immunol 1997, 158:420-425.
18. Erwig L.P., Kluth D.C., Walsh G.M., Rees A.J. Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines. J Immunol 1998, 161:1983-1988.
19. Gazzinelli R.T., Oswald I.P., James S.L., Sher A. Il-10 inhibits parasite killing and nitrogen-oxide production by IFN-gamma-activated macrophages. J Immunol 1992, 148:1792-1796.
20. Oswald I.P., Gazzinelli R.T., Sher A., James S.L. Il-10 synergizes with Il-4 and transforming growth-factor-beta to inhibit macrophage cytotoxic activity. J Immunol 1992, 148:3578-3582.
21. Corradin S.B., Fasel N., Buchmullerrouiller Y., Ransijn A., Smith J., Mauel J. Induction of macrophage nitric-oxide production by interferon-gamma and tumor-necrosis-factor-alpha is enhanced by interleukin-10. Eur J Immunol 1993, 23:2045-2048.
22. Nemoto Y., Otsuka T., Niiro H., Izuhara K., Yamaoka K., Nakashima H., et al. Differential effects of interleukin-4 and interleukin-10 on nitric oxide production by murine macrophages. Inflamm Res 1999, 48:643-650.
23. North R.J. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin Exp Immunol 1998, 113:55-358.
24. Sano C., Sato K., Shimizu T., Kajitani H., Kawauchi H., Tomioka H. The modulating effects of proinflammatory cytokines interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha), and immunoregulating cytokines IL-10 and transforming growth factor-beta (TGF-beta), on anti-microbial activity of murine peritoneal macrophages against Mycobacterium avium-intracellular complex. Clin Exp Immunol 1999, 115:435-442.
25. Silva R.A., Pais T.F., Appelberg R. Blocking the receptor for IL-10 improves antimycobacterial chemotherapy and vaccination. J Immunol 2001, 167:1535-1541.
26. Turner J., Gonzalez-Juarrero M., Ellis D.L., Basaraba R.J., Kipnis A., Orme I.M., et al. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol 2002, 169:6343-6351.
27. Rial A., Lens D., Betancor L., Benkiel H., Silva J.S., Chabalgoity J.A. Intranasal immunization with a colloid-formulated bacterial extract induces an acute inflammatory response in the lungs and elicits specific immune responses. Infect Immun 2004, 72:2679-2688.
28. Rukavina T., Ticac B., Vasiljev V. IL-10 in antilipopolysaccharide immunity against systemic Klebsiella infections. Mediators Inflamm 2006, 10.1155/MI/2006/69431.